Q4 2017 Holdings
Filed 2018-02-14 | 65 holdings | $12.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $5.5M | 43,064 | 45.3% |
| Biogen Inc(BIIB) | COM | 09062X103 | $1.8M | 5,793 | 15.3% |
| Agios Pharmaceuticals Inc(AGIO) | COM | 00847X104 | $1.6M | 28,704 | 13.6% |
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $1.5M | 17,118 | 12.6% |
| Axsome Therapeutics Inc(AXSM) | COM | 05464T104 | $748.0K | 133,500 | 6.2% |
| Akebia Therapeutics Inc(AKBA) | COM | 00972D105 | $312.0K | 21,009 | 2.6% |
| Charles RIV Labs Intl Inc(CRL) | COM | 159864107 | $236.0K | 2,154 | 2.0% |
| Acadia Pharmaceuticals Inc(ACAD) | COM | 004225108 | $207.0K | 6,880 | 1.7% |
| Sage Therapeutics Inc(SG7)Put | COM | 78667J108 | $11.7K | 71,000 | 0.1% |
| Proshares TR(BIB) | PSHS ULT NASB | 74347R214 | $7.3K | 130,500 | 0.1% |
| Spdr Series Trust(XBI) | S&P BIOTECH | 78464A870 | $5.5K | 65,000 | 0.0% |
| Bristol Myers Squibb Co(BMY) | COM | 110122108 | $5.5K | 90,000 | 0.0% |
| Nektar Therapeutics(NKTREUR) | COM | 640268108 | $5.5K | 92,070 | 0.0% |
| Merck & Co Inc(MRK) | COM | 58933Y105 | $4.7K | 83,700 | 0.0% |
| Ignyta Inc | COM | 451731103 | $4.6K | 170,500 | 0.0% |
| Alexion Pharmaceuticals Inc(ALXN)Call | COM | 015351109 | $4.2K | 35,000 | 0.0% |
| Astrazeneca PLC(AZN) | SPONSORED ADR | 046353108 | $4.2K | 120,000 | 0.0% |
| Pfizer Inc(PFE) | COM | 717081103 | $4.1K | 112,300 | 0.0% |
| Ishares TR(IBB) | NASDAQ BIOTECH | 464287556 | $4.0K | 37,500 | 0.0% |
| Bristol Myers Squibb Co(BMY)Call | COM | 110122108 | $2.8K | 45,000 | 0.0% |
| Vertex Pharmaceuticals Inc(VRTX) | COM | 92532F100 | $2.5K | 16,639 | 0.0% |
| Alkermes PLC(ALKS) | SHS | G01767105 | $2.4K | 43,763 | 0.0% |
| Mettler Toledo International(MTD) | COM | 592688105 | $2.2K | 3,594 | 0.0% |
| Glaxosmithkline PLC | SPONSORED ADR | 37733W105 | $2.1K | 60,000 | 0.0% |
| Illumina Inc(ILMN) | COM | 452327109 | $2.1K | 9,717 | 0.0% |
| Ionis Pharmaceuticals Inc(IONS) | COM | 462222100 | $2.0K | 39,388 | 0.0% |
| Seattle Genetics Inc | COM | 812578102 | $1.9K | 35,668 | 0.0% |
| Qiagen NV(QGEN) | SHS NEW | N72482123 | $1.7K | 56,445 | 0.0% |
| Incyte Corp(INCY) | COM | 45337C102 | $1.7K | 18,318 | 0.0% |
| Amgen Inc(AMGN) | COM | 031162100 | $1.7K | 9,924 | 0.0% |
| Regeneron Pharmaceuticals(REGN) | COM | 75886F107 | $1.5K | 4,076 | 0.0% |
| Celgene Corp(CELG) | COM | 151020104 | $1.5K | 14,540 | 0.0% |
| Lilly ELI & Co(LLY)Call | COM | 532457108 | $1.3K | 15,000 | 0.0% |
| Loxo Oncology Inc | COM | 548862101 | $1.2K | 13,800 | 0.0% |
| Alexion Pharmaceuticals Inc(ALXN) | COM | 015351109 | $1.1K | 9,558 | 0.0% |
| Pacira Pharmaceuticals Inc(PCRX) | COM | 695127100 | $1.1K | 25,000 | 0.0% |
| Clovis Oncology Inc(CLVSEUR) | COM | 189464100 | $1.0K | 15,000 | 0.0% |
| Adamas Pharmaceuticals Inc(ADMSEUR) | COM | 00548A106 | $1.0K | 30,000 | 0.0% |
| Proqr Thrapeutics N V | SHS EURO | N71542109 | $992 | 307,692 | 0.0% |
| Karyopharm Therapeutics Inc(KPTIEUR) | COM | 48576U106 | $960 | 100,000 | 0.0% |
| Paratek Pharmaceuticals Inc | COM | 699374302 | $716 | 40,000 | 0.0% |
| Gilead Sciences Inc(GILD)Call | COM | 375558103 | $716 | 10,000 | 0.0% |
| Checkpoint Therapeutics Inc(CKPTUSD) | COM | 162828107 | $438 | 112,760 | 0.0% |
| Tesaro Inc | COM | 881569107 | $414 | 5,000 | 0.0% |
| Ultragenyx Pharmaceutical in(RARE) | COM | 90400D108 | $393 | 8,472 | 0.0% |
| Medicines Co | COM | 584688105 | $383 | 14,000 | 0.0% |
| Bioverativ Inc | COM | 09075E100 | $361 | 6,689 | 0.0% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $326 | 4,204 | 0.0% |
| New SR Invt Group Inc | COM | 648691103 | $316 | 41,850 | 0.0% |
| United Therapeutics Corp del(UTHR) | COM | 91307C102 | $303 | 2,050 | 0.0% |